SILVER SPRING, Md., US: The US Food and Drug Administration (FDA) has finalised guidance on animal studies for dental bone grafting material devices, aiming to reduce reliance on animal testing in premarket submissions. Published in August 2025, the document updates earlier guidance from 2005 and is intended to reflect current review practices, promote consistency and streamline the evaluation of submissions.